Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Elaine Chung
Preclinical Evaluation of the BET Bromodomain Inhibitor BAY 1238097 for the Treatment of Lymphoma
British Journal of Haematology
Hematology
Related publications
The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma
Molecular Cancer Therapeutics
Cancer Research
Oncology
Exploring Selective Inhibition of the First Bromodomain of the Human Bromodomain and Extra-Terminal Domain (BET) Proteins
Identification of a Benzoisoxazoloazepine Inhibitor (CPI-0610) of the Bromodomain and Extra-Terminal (BET) Family as a Candidate for Human Clinical Trials
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
BET Protein Bromodomain Inhibitor-Based Combinations Are Highly Active Against Post-Myeloproliferative Neoplasm Secondary AML Cells
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
BET Bromodomain Proteins Are Therapeutic Targets in CRPC
Cancer Discovery
Oncology
Inhibition of Bromodomain and Extra-Terminal Proteins (BET) as a Potential Therapeutic Approach in Haematological Malignancies: Emerging Preclinical and Clinical Evidence
Therapeutic Advances in Hematology
Hematology
Applying 89Zr-Transferrin to Study the Pharmacology of Inhibitors to BET Bromodomain Containing Proteins
BET Bromodomain Inhibition Releases the Mediator Complex From Select Cis-Regulatory Elements
Cell Reports
Biochemistry
Genetics
Molecular Biology
Cover Feature: Advancements in the Development of Non-Bet Bromodomain Chemical Probes (ChemMedChem 4/2019)
ChemMedChem
Organic Chemistry
Molecular Medicine
Pharmacology
Biochemistry
Toxicology
Drug Discovery
Pharmaceutics